A man or woman, in overall good health
Between 18 and 55 years of age
Non-smoker/Non-Nicotine for at least 90 day
Body Mass Index (BMI) between 19 and 30 kg/m2
How Much: $4,000 (Paid throughout the duration of the study)
Do not forget our REFERRAL PROGRAM. Earn at least $400 paid at dosing. Available to all. for every new participant you refer who completes a study.*
Duration of required contraception for participants assigned female at birth and of childbearing potential enrolled in this clinical study should start from the screening visit until 60 days following administration of study drugs.
Participants assigned female at birth and of childbearing potential must agree to 1 of the following contraceptive methods:
• Complete abstinence from intercourse of reproductive potential. Abstinence is an acceptable method of contraception only when it is in line with the participant’s preferred and usual lifestyle.
Consistent and correct use of 1 of the following methods of birth control listed below:
• Hormonal and nonhormonal intrauterine device
• Bilateral tubal occlusion (upon medical assessment of surgical success)
• Vasectomy in the partner assigned male at birth (upon medical assessment of surgical success)
Participants assigned female at birth and of childbearing potential who initiate use of a hormonal contraceptive > 5 days after onset of menses as their method of birth control should use additional backup contraception (eg, condoms) for 7 days or avoid sexual intercourse for 7 days. Hormonally based contraceptives or barrier methods permitted for use in this protocol are as follows:
• Hormonal methods
Oral contraceptives (either combined or progesterone only)
Subdermal contraceptive implant
Transdermal contraceptive patch
Contraceptive vaginal ring
• Barrier methods
Male condom (with or without spermicide)
Female condom (with or without spermicide)
Diaphragm with spermicide
Cervical cap with spermicide
Sponge with spermicide
Permanent sterilization includes hysterectomy, bilateral oophorectomy, or bilateral salpingectomy in a participant assigned female at birth of any age.
If you have previously submitted an application, call 417-831-2048 to enroll. Or click on the button below to submit your application now.
Apply Online Now